Medicare Enrolled

Dr. Gloria Ortiz, M.D.

Endocrinology · McAllen, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1900 S JACKSON RD STE 1, McAllen, TX 78503
9563404222
In practice since 2010 (16 years)
NPI: 1871825307 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ortiz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ortiz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ortiz

Dr. Gloria Ortiz is an endocrinology in McAllen, TX, with 16 years in practice. Based on federal Medicare data, Dr. Ortiz performed 7,958 Medicare services across 3,374 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ortiz received a total of $535,936 from 38 pharmaceutical and/or device companies across 975 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ortiz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 6% volume in TX$ $535,936 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,958
Medicare services
Top 6% in TX for endocrinology
3,374
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~497 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes1,076$31$75
Denosumab injection (Prolia/Xgeva)780$19$45
Remote patient monitoring management, 20 min/month656$37$90
Office visit, established patient (30-39 min)593$86$185
Remote patient monitoring device, 30 days507$37$105
Blood draw (venipuncture)462$8$14
Free thyroxine (T4) test314$9$20
Thyroid stimulating hormone (TSH) test308$16$35
Thyroid hormone, t3 measurement, free303$16$35
Chronic care management, additional 20 min/month258$37$100
Blood glucose (sugar) test performed by hand-held instrument250$3$10
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month242$44$105
Vitamin D level test214$28$60
Hemoglobin A1c test (diabetes monitoring)205$9$20
Chronic care management, first 20 min/month141$49$100
Vitamin B-12 level test140$14$30
Ultrasound scan of head and neck soft tissue136$82$200
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report126$26$55
Comprehensive metabolic blood panel109$10$24
Drug injection, under skin or into muscle107$10$30
Urine microalbumin test (kidney screening)106$6$10
Creatinine test (kidney function)106$5$10
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg89$1$5
Ultrasound scan of growth for measuring elasticity, first growth80$72$165
Lipid panel (cholesterol and triglycerides)78$13$25
New patient office visit (45-59 min)69$96$250
Ultrasound scan of growth for measuring elasticity, each additional growth62$47$105
Microsomal antibodies (autoantibody) measurement61$14$25
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment61$102$215
Ultrasound study of arm and leg arteries54$54$140
Evaluation of fine needle aspirate33$41$100
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode33$22$55
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment31$15$35
Retinal photography (fundus photo)30$24$90
Office visit, established patient, complex (40-54 min)25$140$250
Ultrasound scan of organ tissue for measuring elasticity24$81$175
Complete blood count (CBC) with differential24$8$15
New patient office visit, complex (60-74 min)21$159$300
Fine needle aspiration biopsy using ultrasound guidance, first growth16$102$225
Cortisol (hormone) measurement, total16$16$30
Office visit, established patient (20-29 min)12$59$125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$535,936
Total received (2018-2024)
Avg $76,562/year across 7 years
Top 5% in TX for endocrinology
38
Companies
975
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$522,599 (97.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,904 (1.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,433 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$69,088
2023
$61,654
2022
$110,744
2021
$116,448
2020
$43,500
2019
$66,987
2018
$67,516

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$216,326
Janssen Pharmaceuticals, Inc
$92,993
Boehringer Ingelheim Pharmaceuticals, Inc.
$68,114
Lilly USA, LLC
$43,162
SANOFI-AVENTIS U.S. LLC
$32,938
Bayer HealthCare Pharmaceuticals Inc.
$31,979
Bayer Healthcare Pharmaceuticals Inc.
$20,533
Xeris Pharmaceuticals, Inc.
$18,146
Ascendis Pharma Inc
$4,220
Rhythm Pharmaceuticals, Inc.
$3,386
Abbott Laboratories
$819
AstraZeneca Pharmaceuticals LP
$434
Senseonics, Incorporated
$400
Amgen Inc.
$279
Amarin Pharma Inc.
$278
Insulet Corporation
$201
Dexcom, Inc.
$191
Corcept Therapeutics
$166
Janssen Scientific Affairs, LLC
$163
Medtronic, Inc.
$153
Madrigal Pharmaceuticals
$150
MannKind Corporation
$138
Novartis Pharmaceuticals Corporation
$137
Intuitive Surgical, Inc.
$129
Tempus AI, Inc
$66
Alexion Pharmaceuticals, Inc.
$64
Medtronic MiniMed, Inc.
$49
Tandem Diabetes Care, Inc.
$49
DEXCOM, INC.
$49
Radius Health, Inc.
$43
Intuity Medical Inc
$37
Antares Pharma, Inc.
$33
BETA BIONICS, INC.
$25
Shire North American Group Inc
$23
Ipsen Biopharmaceuticals, Inc
$21
Regeneron Healthcare Solutions, Inc.
$16
IBSA Pharma Inc.
$14
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 70.4% of total payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BYDUREON · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · DISEASE STATE · Da Vinci Surgical System · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · HUMULIN · INVOKAMET · INVOKANA · Imcivree · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · Levemir · MINIMED 780G · MOUNJARO · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · Omnipod · Otrexup · Ozempic · PRALUENT ALIROCUMAB INJECTION · Pogo Automatic Blood Glucose Monitoring System · Prolia · REZDIFFRA · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · Saxenda · Somatuline Depot · Strensiq · TOUJEO · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for endocrinology in TX.

Equivalent to $6,735 per 100 Medicare services performed
Looking for a endocrinology in McAllen?
Compare endocrinologys in the McAllen area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
10
Per 100K population
1.1
County median income
$52,281
Nearest hospital
RIO GRANDE REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ortiz is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), and high industry engagement (speaking/promotional, top 5%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ortiz experienced with management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes?
Based on Medicare claims data, Dr. Ortiz performed 1,076 management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ortiz receive payments from pharmaceutical companies?
Yes. Dr. Ortiz received a total of $535,936 from 38 companies across 975 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ortiz's costs compare to other endocrinologys in McAllen?
Dr. Ortiz's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ortiz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →